Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis

Affiliations

• ¹ DeltaQuest Foundation, Inc., Concord, MA, USA/Departments of Medicine and Orthopaedic Surgery, School of Medicine, Tufts University, Boston, MA, USA.
• ² Department of Neuroscience and Mental Health, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
• ³ DeltaQuest Foundation, Inc., Concord, MA, USA.
• ⁴ Hospital for Sick Children, Toronto, ON, Canada/Division of Neurology and Division of Neuroscience and Mental Health, Department of Pediatrics, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.
• ⁵ Division of Neurology, Department of Pediatrics, Cumming School of Medicine, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
• ⁶ Departments of Neurology and Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
• ⁷ Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
• ⁸ Division of Neurology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• ⁹ Division of Child Neurology, Department of Pediatrics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
• ¹⁰ Department of Neurology, The Mellen Center, Cleveland Clinic, Cleveland, OH, USA.
• ¹¹ Departments of Neurology and Pediatrics, University of Colorado Denver, Denver, CO, USA.
• ¹² Department of Neurology, University of San Francisco, San Francisco, CA, USA.
• ¹³ Division of Neurology and Department of Neuroscience and Mental Health, Department of Pediatrics, Research Institute, Hospital for Sick Children, Toronto, ON, Canada/Faculty of Medicine, The University of Toronto, Toronto, ON, Canada.